Results 151 to 160 of about 552,283 (212)

Systematic review of prophylactic antibacterial agents for radiation-induced oral mucositis in head and neck cancer. [PDF]

Support Care Cancer
Alicea DS, Han M, Islam Z, Schwartz R, Ow TJ, Mehta V, Garg M, McLellan BN, Kabarriti R.   +8 more
europepmc   +1 more source

Spi-1 proto-oncogene regulates mRNA hypertranscription and malignant progression in head and neck cancer. [PDF]

Signal Transduct Target Ther
Liu Z, Qin Z, Li H, Zhu L, He L, Chen N, Zhu D, Liu Q, Dai L, Peng X.   +9 more
europepmc   +1 more source

High UBE2D1 expression is associated with poor prognosis and immunotherapy resistance in head and neck cancer. [PDF]

J Oral Biol Craniofac Res
Prasad P, Arumugam P.
europepmc   +1 more source

Genomic Aberrations of Antisense Gene Transcripts in Head and Neck Cancer. [PDF]

Cells
Ye J, Abbang SM, Ng YK, Lui VWY.
europepmc   +1 more source

Examining Association of Receipt of Dental Care With Late-Stage Head and Neck Cancer. [PDF]

Perm J
Mosen D, Petrik A, Hammon R, Pihlstrom D, Varga A, Gautom P, Banegas M.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Head and neck cancer

The Lancet, 2021
Head and neck cancer is the seventh most common type of cancer worldwide and comprise of a diverse group of tumours affecting the upper aerodigestive tract. Although many different histologies exist, the most common is squamous cell carcinoma.
Mayur D, Mody, James W, Rocco, Sue S, Yom, Robert I, Haddad, Nabil F, Saba   +4 more
openaire   +2 more sources